1,703
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies

, , , , , , , , , & show all
Pages 11-20 | Received 17 Jan 2014, Accepted 12 Mar 2014, Published online: 20 May 2014

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.